November 19, 2020
FDA authorizes first home test for COVID-19
Editor's Note
The Food and Drug Administration (FDA) on November 17 issued an emergency use authorization for the first rapid COVID-19 self-test that a person can administer at home.
The Lucira COVID-19 All-In-One Test Kit has to be prescribed by a healthcare provider, and the healthcare provider has to report the results to public health authorities. The home test is for those 14 years of age or older.
The test also can be used in patient care settings, with nasal swab specimens collected by the provider in those under age 14.
Free Daily News
- Catheter sterility concerns prompt Class 1 FDA recall for surgery trays
- Large amounts of personal data possibly stolen in Change Healthcare cyberattack
- AI model helps predict patient decline, drive collaborative care
- One patient’s recovery highlights benefits of outpatient endoscopic spine surgery
- Getting ready for the OAS CAHPS Survey 2025 requirement
- Contribute to perioperative education with the 2024 OR Manager Salary/Career Survey
- Supply chain stability improves, but threats remain
- Private equity healthcare ownership draws new scrutiny
- Share your expertise! Topics, speakers sought for 2025 ORBMC
- FDA approves imaging drug for detecting cancer after lumpectomy
© Access Intelligence, LLC. All rights reserved. | Privacy Policy | Diversity, Equity, Inclusion & Belonging